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ABSTRACT
Objective: To estimate the prevalence of, and factors
associated with, dilated eye examination guideline
compliance among patients with diabetes mellitus
(DM), but without diabetic retinopathy.
Research design and methods: Utilizing the
computerized billing records database, we identified
patients with International Classification of Diseases
(ICD)-9 diagnoses of DM, but without any ocular
diagnoses. The available medical records of patients in
2007–2008 were reviewed for demographic and ocular
information, including visits through 2010 (n=200).
Patients were considered guideline compliant if they
returned at least every 15 months for screening.
Participant street addresses were assigned latitude and
longitude coordinates to assess their neighborhood
socioeconomic status (using the 2000 US census
data), distance to the screening facility, and public
transportation access. Patients not compliant, based on
the medical record review, were contacted by phone or
mail and asked to complete a follow-up survey to
determine if screening took place at other locations.
Results: The overall screening compliance rate was
31%. Patient sociodemographic characteristics,
insurance status, and neighborhood socioeconomic
measures were not significantly associated with
compliance. However, in separate multivariable logistic
regression models, those living eight or more miles
from the screening facility were significantly less likely
to be compliant relative to those living within eight
miles (OR=0.36 (95% CI 0.14 to 0.86)), while public
transit access quality was positively associated with
screening compliance (1.34 (1.07 to 1.68)).
Conclusions: Less than one-third of patients returned
for diabetic retinopathy screening at least every
15 months, with transportation challenges associated
with noncompliance. Our results suggest that reducing
transportation barriers or utilizing community-based
screening strategies may improve compliance.
The number of American adults 20 years of
age and older living with diabetes mellitus
(DM) has increased by approximately 75%
over the past two decades, with the largest
absolute increases in prevalence occurring in
those 65 years of age and older.1 Symptoms
of the early stages of DM are frequently
missed; in 2010, there were an estimated
seven million Americans of all ages living
with undiagnosed diabetes.2 Diabetic retin-
opathy is a complication of DM; the risk of
diabetic retinopathy increases with the
number of years of living with this condi-
tion.3 Diabetes treatment is complex and
poor management is a major risk factor for
the development of retinopathy.3 Diabetic
retinopathy is the leading cause of blindness
in US adults over the age of 40 despite the
availability of effective treatment.3 4 By 2050,
the number of Americans aged 40 years or
older and living with DM is expected to
triple to 16 million, with over 3 million
having advanced vision-threatening disease.5
Early detection of diabetic retinopathy is
critical, given that prompt treatment
increases the likelihood of preserving vision.3
Unfortunately, many adults living with DM
remain unaware of their ocular condition
until their diabetic retinopathy has pro-
gressed to a stage at which treatment is
difficult.6 The American Academy of
Key messages
▪ Dilated eye examination guideline compliance
among patients with diabetes mellitus is low.
▪ Quality of access to public transportation was
positively correlated with screening compliance.
▪ Transportation assistance interventions and more
comprehensive community-based screening
models need to be developed and tested.
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Ophthalmology, to encourage early detection of diabetic
retinopathy, endorses annual dilated eye examinations
for patients with type 1 and 2 diabetes.7 Additionally, the
American Diabetes Association recommends annual
dilated eye examinations after diagnosis of DM,
although the guidelines leave some flexibility for less fre-
quent ocular examinations by ophthalmologists or opto-
metrists in the presence of one or more normal eye
examination results.8
Unfortunately, not everyone who should do so receives
annual dilated eye examinations. Factors which influ-
ence screening compliance include lack of insurance
and healthcare access, knowledge of diabetes-specific
ocular risk, and health literacy, cultural, and language
barriers.9–12 An analysis of Medicare claims data found
that slightly more than 50% of patients with newly diag-
nosed DM had at least one 15-month gap between eye
examinations during the first 30 months of living with
this condition.13 Among enrollees of an independent
practice association, only 16% of those with diabetes
underwent annual eye examination in two consecutive
years.14 Yearly reminders to those enrolled in one large
managed care organization yielded only a 28% 1-year
reexamination rate.15
While it is important to evaluate adherence for all
persons with diabetes, regardless of whether retinopathy
has already been diagnosed, there is scant literature
about screening adherence in persons with diabetes who
do not have a retinopathy diagnosis. We identified
factors associated with compliance for annual dilated
eye examination guidelines among patients with diag-
nosed DM, but without diabetic retinopathy. Given that
geographic access to healthcare and screening facilities
is critically important for compliance, poor access (such
as longer traveling time, high transportation cost, and
burdensome public transportation options) can be a
potent barrier.16–18 However, to the best of our knowl-
edge, no study has examined the association between
compliance and ease of access to screening sites via
public transportation. Here, we examine how compli-
ance was associated with patient-level factors, as well as
distance from the screening facility and transit score, a
measure of access to public transport facilities.
RESEARCH DESIGN AND METHODS
Medical record identification and review
Utilizing computerized billing records, we selected the
Bascom Palmer Eye Institute patients initially seen with
International Classification of Disease (ICD)-9 diagnoses
of DM (types 1 and 2) without diabetic complications
and without diabetic retinopathy or any other eye
disease. Since we were interested in examining
transit-related compliance factors, we further restricted
our sample to patients who resided within the same
county as the screening facility (ie, Miami-Dade
County). The sample of available and eligible patient
records first seen in 2007–2008 (n=203) was reviewed for
demographic information (eg, age, sex, and race/ethni-
city) at the screening visit, and all clinic visits through
2010 were ascertained by chart review. Insurance status
was obtained from medical billing records based on
current information available as of June 2, 2011. On
review, three patients had diabetic retinopathy diagnoses
recorded in their medical record and were eliminated,
resulting in a final sample size of 200 patients.
Diabetic retinopathy screening compliance
Although compliance guidelines for dilated eye exami-
nations specify annual visits, we defined compliance in
our sample as returning at least every 15 months (coded
as 0=noncompliant, 1=complaint). We chose 15 months
to account for annual scheduling variations, such as
patient/provider-requested scheduling issues or being
away from the area as a consequence of travel or other
reasons.13
Participant follow-up
To determine if they received care at a location other
than the Bascom Palmer Eye Institute, we attempted to
call those patients whose medical records indicated that
they were not guideline compliant. A minimum of five
attempts were made. Patients who were unreachable by
telephone were mailed a questionnaire sent to their last
known address. A total of 45 and 8 patients, respectively,
completed the telephone interviews or returned the
mailed questionnaires.
Census data abstraction
Each participant’s last known address was geocoded to
abstract sociodemographic neighborhood characteristics
using publicly available block and tract-level data from
the 2000 US Census. While demographic data (such as
race/ethnicity and household information) were avail-
able at the block level, economic data were only avail-
able at the census tract level. Generally, a block is small
in area; for example, a block in a city is bounded on all
sides by streets. Blocks are nested within block groups
and block groups within census tracts. The population
size of a census tract ranges from 1200 to 4000 people.19
Abstracted data fields included: the average age of the
head of the household, the number of people with
white race designation, the percent of households with
married couples, the median household income, the
percent of families receiving public assistance, the
median real estate taxes, and the percent of owner occu-
pied households.
Transit score variable creation
Bascom Palmer Eye Institute, the eye care facility, is
located near downtown Miami, which is connected to
most public transport facilities (metro rail and bus ser-
vices). We first calculated the Euclidean distance (in
miles) between the eye care facility and residential loca-
tions of participants. This point-to-point calculation is a
crude indicator of the level of geographic access to the
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eye care facility since it does not take into account
roadway patterns and the availability of public transpor-
tation to the site. We therefore extracted data from the
Walk Score website using web-mining techniques
(http://www.walkscore.com/).20 Walk Score values
range between 0 and 100. A transit score of 0–24 is
coded as ‘minimal transit’ and 90–100 is coded as
‘Rider’s paradise’. We sent five random locations within
half a mile of each participant’s residence to the Walk
Score and acquired transit score estimates for each of
the five locations. We then computed the average of
these five scores, assigning for each the average transit
score to each respective participant. We had two major
categories of Walk Score values: minimal transit and all
others. Since places with minimal transit options have
similar characteristics (poor access to public transport
facilities) and the rest of the places increment quantita-
tively with the increase in transit facilities, we converted
the Walk Score to an ordinal scale by assigning 1 to all
Walk Scores <20, and by dividing the rest by 10. The
resulting scale then ranged from 1 to 10.
Statistical analyses
Comparisons of patient-level factors and US census-
derived estimates of neighborhood sociodemographic
status as a function of compliance status were made at
the univariate level using the IBM/SPSS statistical
package (IBM SPSS Statistics V.21). The means of age
and socioeconomic variables in compliant versus non-
compliant participants were compared using analysis of
variance. The statistical significance of associations
between sex, race/ethnicity, and health insurance status
was assessed with the χ2 test.
Logistic regression modeling was employed to
examine the association between transit scores and
select individual-based and area-based measures with
adjustment for the spatial trend using the logit function
with a robust SE option in Stata (STATA/SE V.10.1). We
first undertook multivariable analyses to determine if
the Euclidean distance between the eye care facility and
the patients’ home was associated with compliance. In
this analysis, we partitioned distance using the average
distance into two categories: less than the average dis-
tance coded as 0, and the rest coded as 1 (<8 vs ≥8
miles). In separate logistic regression modeling, we
examined the association between transit score and com-
pliance. Given that there was evidence of spatial trends
in these data (ie, presence of similarities in geographic
distribution of compliance and noncompliance), a
distance-weighted autocovariate was generated in R
using the spdep library which was included as a covariate
in the regression models.21 22
For both sets of analyses, we employed a stepwise
approach to demonstrate how compliance varies with
transit scores with and without the control for individual-
based and area-based measures and spatial trend. We
first modeled the association of transit score with com-
pliance independent of any other variables (model 1),
followed by a model which controlled for spatial auto-
correlation (model 2). The next model included spatial
autocorrelation and patient-level factors including age,
sex, and insurance status (model 3). The final model
included these variables along with two representative
census-based neighborhood sociodemographic indica-
tors, namely the percentage of neighborhood white race
designation and median household income. Results
were considered significant if p<0.05.
RESULTS
Characteristics of the study population are provided in
table 1. Patients averaged 51 years of age with slightly
more women than men (53%). The sample was diverse
with respect to race/ethnicity with 43% Hispanic, and
23% reporting their race as African-American,
non-Hispanic. Nearly half (46%) had public insurance
(eg, Medicaid and Medicare) with another 44% report-
ing being privately insured. The median neighborhood
household income was slightly less than $35 000, which
was below the median amount of $39 425 for all resi-
dents of Miami-Dade County in the year 2000. However,
the percentage of patients living in neighborhoods with
families receiving public assistance was low (7.4%), and
was slightly higher than the percentage for the entire
county (6.8%).
Incorporating results from the telephone and mailing
outreach efforts yielded an estimated compliance rate of
31% (62/200). Of the 200 patients, 12.5% (n=25) were
judged to be guideline compliant based on a medical






Screening age 198 50.9 1.2
Female 107 53.5%
Race-ethnicity
Black, non-Hispanic 45 22.5%




Uninsured (self-pay) 18 9.8%
Public insurance 85 46.4%
Private insurance 80 43.7%
Area-based characteristics
Average household age (years) 195 38.5 9.4
Percentage of white population 195 62.1 2.1
Percentage of married couples 195 64.1 0.8
Median household income ($) 195 34 984 780
Percentage of families receiving
public assistance
195 7.4 0.3
Median real estate taxes ($) 195 1828 62
Percentage of owner occupied
houses
195 56.3 1.2
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record review. Of the 175 patients whose medical records
indicated that they were not guideline compliant, 30%
(n=53) completed a telephone interview (n=45) or
returned a mailed questionnaire (n=8). Seventy percent
(37/53) of these patients indicated that they had received
follow-up care every 15 months from other providers and
were reclassified as compliant. Since we were unable to
reach 122 of the potentially noncompliant patients, we
compared the patient-level and area-based census
characteristics of those who did and did not complete
either a telephone or mail survey and found no statistically
significant differences between groups (results not shown).
Neither patient characteristics nor neighborhood
socioeconomic measures were significantly associated
with compliance (table 2). Those living eight or more
miles from the eye care facility were not significantly dif-
ferent from those living within eight miles in being com-
pliant with dilated eye examinations (models 1–3; table
3). However, in model 4, which adjusted for age, sex,
insurance status, median neighborhood household
Table 2 Sociodemographic characteristics among study participants compliant and noncompliant with screening guidelines
Characteristic
Not fully compliant
(n=138) Fully compliant (n=62)
p ValueMean/per cent SE Mean/per cent SE
Individual level
Age 52.0 1.4 48.4 2.4 0.17
Sex 1.00
Male (n=92) 68.5% 31.5%
Female (n=107) 69.2% 30.8%
Race-ethnicity 0.47
Black, non-Hispanic (n=45) 75.6% 24.4%
White, non-Hispanic (n=35) 68.6% 31.4%
Hispanic (n=86) 65.1% 34.9%
Insurance status 0.08
Uninsured (self-pay) (n=18) 77.8% 22.2%
Public insurance (n=85) 60.0% 40.0%
Private insurance (n=80) 75.0% 25.0%
Area-based characteristics
Average household age (years) 38.3 0.8 39.2 1.2 0.54
Percentage of white population 60.9 1.4 55.5 2.3 0.40
Percentage of married couples 63.9 1.0 64.4 1.5 0.78
Median household income ($) 34 867 926 35 247 1455 0.82
Percentage of families receiving public assistance 7.5 0.3 7.4 0.5 0.94
Median real estate taxes ($) 1803 77 1885 106 0.55
Percentage of owner occupied houses 56.7 1.4 55.5 2.3 0.64



















OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Distance to facility (<8 miles=reference
vs ≥8 miles)
0.64 0.35 to 1.18 0.55 0.29 to 1.06 0.52 0.27 to 1.01 0.36* 0.14 to 0.86
Age (<45 years (reference) vs 45+) 0.63 0.32 to 1.26 0.67 0.33 to 1.37
Sex (male=reference vs female) 0.82 0.43 to 1.53 0.86 0.45 to 1.62
Insurance (yes=reference vs no) 0.61 0.26 to 1.42 0.70 0.30 to 1.66
Percentage of white population in the
neighborhood
1.00 0.99 to 1.02
Median household income in the
neighborhood
1.00 1.00 to 1.00
*p<0.05.
4 BMJ Open Diabetes Research and Care 2014;2:e000031. doi:10.1136/bmjdrc-2014-000031
Perspectives in diabetes
income, racial neighborhood composition, and spatial
autocorrelation, living more than eight or more miles
from the eye care facility was associated with a lower
odds of compliance (OR=0.36 (95% CI 0.14 to 0.86)).
Transit score also showed a significant association with
the probability of compliance in models 2–4 (table 4).
In the fully adjusted model 4, the OR was 1.34 (1.07 to
1.68), indicating that after covariate adjustment the com-
pliance rate increases by 34% with a 1-unit (or 10%)
increase in the transit score.
DISCUSSION
We found that all examined patient-level and
neighborhood-level census measures failed to distinguish
between patients with diabetes diagnosis who did and
did not have dilated eye examinations at least every
15 months during the 24–36-month study period.
However, after adjusting for demographics, those living
more than eight miles from the eye care facility were less
likely to be compliant. We also found that the quality of
access to public transportation was strongly associated
with compliance. We do not believe that an association
between the quality of public transportation access and
dilated eye examination compliance has ever been
reported in the scientific literature. Both distance to the
eye care facility and transit score are highly correlated
(r=0.72, p<0.001), which precluded modeling both sim-
ultaneously. However, of the two measures, we believe
that the findings for transit score, which captures the
ease with which a person can return for repeat eye
examinations, especially individuals who do not have
motor vehicle access, have the most implications for
improving compliance in urban settings. This is espe-
cially relevant for interpretation of results since the eye
care facility is contracted to provide ophthalmic care for
county residents lacking healthcare access.
Our findings suggest that transportation access is one
barrier that could be addressed through interventions
designed to lower such barriers via travel vouchers and
arranging for transportation to eye care facilities.
However, even the provision of free transportation may
not mitigate these low compliance rates, especially in eco-
nomically distressed communities. For example, in one
comprehensive community-based eye disease screening
program, those who tested positive and needed follow-up
care were offered free transportation to the clinic site.
Despite this offer, only about 50% of those who agreed to
the follow-up examination completed the visit.23
Thus, unless they are paired with interventions
designed to increase compliance with eye care guide-
lines, interventions focused solely on lowering transpor-
tation barriers may not substantially improve compliance
rates. A randomized trial testing an educational interven-
tion targeting African-Americans with diabetes but with
no dilated eye examination in the previous 14 months
yielded a significantly higher subsequent examination
rate in those in the intervention versus usual care arms
of the trial (55% vs 27%).24 In a recent analysis of data
from the Behavioral Risk Factor Surveillance System, par-
ticipants 40 years of age or older with a self-reported
diagnosis of diabetes were significantly more likely to
report seeing an eye care provider in the previous
12 months if they also indicated a history of receiving
diabetes education (57% vs 43%, p<0.001).25 Although
speculative, these findings raise the possibility that those
living with diabetes may be more responsive to transpor-
tation interventions if they also receive education on the
importance of routine eye examinations.
Alternately, results of the present analysis suggest that
dispersed eye care access throughout communities could
be more effective in increasing dilated eye examination
compliance rates.23 Such screening efforts could specific-
ally target communities with poor transportation access,



















OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Transit score 1.19 1.00 to 1.43 1.25* 1.05 to 1.50 1.24* 1.04 to 1.50 1.34* 1.07 to 1.68
Age (<45 years (reference) vs 45+) 0.68 0.34 to 1.37 0.71 0.34 to 1.50
Sex (male=reference) 0.90 0.48 to 1.70 0.99 0.52 to 1.88
Insurance (yes=reference vs no) 0.62 0.25 to 1.47 0.72 0.29 to 1.76
Percentage of white population in the
neighborhood
1.01 0.99 to 1.02
Median household income in the
neighborhood
1.00 0.99 to 1.00
*p<0.05.
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and could include ongoing efforts to educate those living
with diabetes on the importance of regular eye examina-
tions. However, the challenges of increasing compliance
rates, particularly in underserved communities, cannot
be overemphasized.26 For example, one previous inter-
vention targeting low-income urban diabetic adults who
had not had a recent eye examination found that tele-
phone prompts led to an increased 6-month dilated eye
examination rate over those randomized to receive
mailed prompts. However, rates for both groups
remained suboptimal: 34% vs 20%.11 Embedding a tele-
medicine screening program within a federally qualified
health center targeting the medically underserved nearly
doubled the proportion of diabetic patients who were
screening compliant; however, the overall percentage of
compliant patients was still below 25%.27 Our findings,
combined with the aforementioned modest intervention
results, raise the possibility that in order to substantially
increase dilated eye examination rates in the medically
underserved urban populations, it may be necessary to
combine direct marketing of eye care opportunities, such
as tailored phone interventions and intensive community
engagement, for the purposes of educating target popu-
lations on the need for regular eye examinations. This
approach could be combined with eye care modalities
delivered via mobile examination units sent directly to
patient addresses or to nearby community centers. There
has been some success in the use of community health
workers to facilitate screening compliance and follow-up
rates targeting other conditions28–31; therefore, programs
with high visibility, ease of access, and embedded within
integrative chronic care models may gradually reduce the
number of persons with diabetes who do not undergo
annual eye examinations, while simultaneously improving
overall diabetes care management.28–31
Study limitations
Our study was limited by the incomplete follow-up of
those judged to be noncompliant based on a medical
record review. We had only limited success in reaching
these patients by phone or mail. Therefore, our compli-
ance rate of 31% is most likely an underestimate of the
true rate. This misclassification may have also influenced
our ability to accurately identify predictors of compli-
ance. Our relatively small sample size, combined with
lack of information in the medical record, prevented us
from examining the role of language barriers in compli-
ance rates. Finally, this study took place in an urban
setting, so results may not generalize to those living in
suburban and rural settings.
CONCLUSIONS
Less than one-third of patients in our study were compli-
ant with dilated eye examination guidelines. Compliance
was associated only with living within eight miles from
the eye care facility and more strongly with quality of
access to public transportation in the urban setting in
which this study took place. Study results reinforce the
notion that the current environment for routinely
meeting dilated eye examination guidelines is far from
adequate, and new models which seamlessly embed eye
care and educational opportunities within communities,
with robust mechanisms for follow-up care for those who
test positive, need to be developed and tested.
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